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Every year, thousands of babies and children in low- and middle-income 
countries lose their sight and their lives to a treatable childhood eye cancer called 
retinoblastoma; usually because it was not recognised and treated in time. 
Although retinoblastoma is relatively uncommon, it can have devastating consequences for the children affected by it. If treated too late, it can lead 
to the loss of the eye, invasion of the brain and death. 
Retinoblastoma does not affect everyone equally. In 
high-income countries, fewer than 5% of children die 
as a result of the condition, thanks to early diagnosis 
and specialist treatment. In Africa, however, it is typical 
to see 70% of children with retinoblastoma die, mainly 
because they presented too late. When mothers 
do present at a tertiary centre with a child who has 
advanced retinoblastoma, they often report that they 
have had several interactions with different health 
professionals over many months or even years, but did 
not get the referral or care they needed. Every health 
professional reading this issue of the Community Eye 
Health Journal has a chance to redress this balance. We 
need to find and treat children with retinoblastoma 
early, before it causes disfigurement or death. 
Doing so successfully requires adopting a multidisciplinary, 
multi-level and internationally collaborative approach 
that looks at the health system as a whole (see page 4). 
Raising awareness of retinoblastoma in the community, 
improving the detection and diagnosis of the condition, 
setting up good referral systems and offering good 
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counselling and high quality treatment (including 
good prosthetics) are all needed to increase the 
uptake of services and save lives.
Ministry of health 
Ministries of health have the power to made 
dramatic improvements to the early detection and 
treatment of retinoblastoma. They can: 
• Create public health campaigns to raise 
awareness that ‘seeing something white’ inside a 
child’s eye is a medical emergency 
• Include basic ocular history taking and eye 
examination techniques in the curriculum of 
community nurses
• Off er subsidised access to specialist treatment 
for children with this life-threatening condition. 
Parents must be made aware that they should 
seek help urgently if they see something white 
inside their child’s eyes. Emphasise that parents 
should not let their child be turned away and must 
not take ‘no’ for an answer if they feel there is 
something wrong.
A worthwhile investment
Investing resources in the early detection and 
referral of children with retinoblastoma has wider 
benefi ts in the fi elds of childhood blindness in 
low- and middle-income countries, as the same 
criteria (something white in the eye) will also help 
with the early detection of childhood cataract. Late 
presentation of childhood cataract is the leading 
cause of treatable blindness in children, and is 
entirely preventable if cataracts are detected and 
treated in time. 
In the community
Nurses and health workers seeing children in 
the community can check children’s eyes during 
routine immunisation appointments, for example. 
Something abnormal, white or shiny, or a 
squint, may be the fi rst sign of retinoblastoma 
and requires urgent specialist referral. Listen to 
VOLUME 31 • NUMBER 101 • 2018
About this issue
Retinoblastoma is a rare condition with devastating 
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the parents and/or carers. If they have seen something 
white or abnormal in their child’s eye, believe what they 
say, take it seriously and seek specialist advice. 
In Tanzania, community nurses have been trained 
to examine the red refl ex (p. 23) using an Arclight 
ophthalmoscope. The Arclight is an aff ordable, solar-
powered and easy-to-use ophthalmoscope. It has 
shown preliminary promise; the community nurses 
found it easy to learn and began picking up cases of 
cataract and retinoblastoma by using it. Nurses can 
learn how to examine the red refl ex at the same time as 
examining the child’s other systems. 
Tertiary centres
At tertiary centres, histopathologists have a crucial role: 
once the eye is removed the child may be able to leave 
hospital completely cured or may need chemotherapy 
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or radiotherapy; this decision must be based on 
accurate histopathological staging (page 18).
International collaboration
To promote this multi-level, multi-disciplinary and 
internationally collaborative approach, the Commonwealth 
Eye Health Consortium has provided start-up funding for 
an Rb-Network known as Rb-NET, which has already 
generated specifi c country plans, a set of core outcome 
indicators, best practice protocols and a practical resource 
manual (http://cehc.lshtm.ac.uk/dr-links/rbnet/). 
Basic clinical research questions still need to be 
answered. For instance, researchers in Uganda 
have shown an improvement in survival by giving 
chemotherapy before surgery on the basis that so 
many children have extra-ocular spread at time of 
presentation. On the other hand, a small study from 
Tanzania showed that 60% of children for whom there 
was good histology after enucleation had complete 
excision of the tumour with low risk and never needed 
chemotherapy. So which should come fi rst in these 
settings – chemotherapy or surgery? By combining 
multi-centre and multi-country clinical research, as 
Rb-NET has started to do, we can begin to answer these 
questions and prevent needless tragedies. 
This issue of the Journal demonstrates that there is real 
momentum and determination to improve outcomes 
for children with Rb in all countries across the world. It 
contains concise, practical information that should help 
all of us to make a diff erence. 
Rb-NET website
http://cehc.lshtm.ac.uk/
dr-links/rbnet/
Resource manual
http://cehc.lshtm.ac.uk/
resource-manual-for-rb-
management-v-
sept-1-002/
Arclight
www.arclightscope.com
Individual responsibilities
Parent ➔ Health worker/nurse ➔ Ophthalmologist ➔ Specialist eye centre
Seek help urgently if you 
see something white inside 
the centre of the eye (the 
pupil) OR if you take a 
photograph and only one 
eye has a red dot in the 
centre
Do not let anyone turn you 
away and do not take no for 
an answer until a doctor at 
a hospital has examined the 
child’s eyes using a bright 
light
Believe the parents if they say 
they have seen something 
white inside the pupil and seek 
specialist advice. Treat it as a 
medical emergency
Learn how to test the red 
refl ex (p. 23). Test all children 
during routine visits and 
immunisations
Learn to recognise 
retinoblastoma and to identify 
eyes that need enucleation
Counsel parents about the good 
cosmetic outcomes of 
enucleation with implantation. 
Show pictures of children with 
good outcomes
Learn how to enucleate, taking 
more than 15 mm of optic 
nerve. Always examine the 
fundus of the fellow eye when 
you perform an enucleation: 
there could be a small tumour 
which is treatable by laser
Refer all children with signs of 
retinoblastoma in two eyes to a 
national or specialist centre for 
urgent treatment
Same as for ophthalmologists, plus:
Learn how to give focal or laser 
treatment to smaller tumours 
(usually in the second eye)
Create multidisciplinary teams who 
work closely together to coordinate 
the treatment of each child
Include in this team: 
ophthalmologists, oncologists, 
histopathologists, nurses, child life 
specialists or play therapists and/or 
counsellors
Off er general and genetic counselling 
to parents/carers
Refer parents to other sources of 
support for their child’s learning and 
development
The Ministry of Health’s responsibilities towards the above
Run public awareness 
campaigns so that parents 
know that treatment is 
possible and know when to 
see a doctor
Ensure that the red refl ex test
(p. 23) is included in the 
curriculum for nurses and health 
workers
Ensure there is at least one 
ophthalmologist per 100,000 
population 
Support the development of national 
retinoblastoma centres and referral 
networks. Off er subsidised access to 
specialist treatment for all children with 
retinoblastoma. Provide screening 
services for siblings and accommodation 
or travel subsidies for the parents or 
carers of these young children.
Table 1 Roles and responsibilities in the detection, referral and treatment of retinoblastoma
I am a child, not a case
Patients with retinoblastoma are fi rst and foremost 
children who happen to have cancer in their eye(s). 
Defi ning a child as a ‘case’ dehumanises them and 
draws attention away from thoughts about their 
complete wellbeing and that of their family.
A child with retinoblastoma is not a medical 
specimen. They are a complete individual with 
thoughts, feelings, hopes, dreams, likes and 
dislikes. They have the ability to generate every 
kind of emotion in those who care for them. They 
are desperately loved, and most parents would give 
their own eye if it could spare their child’s suff ering. 
In evaluating diff erent treatments, we must weigh 
the value of each treatment in relation to the child’s 
complete wellbeing. We must look beyond the physical 
body to embrace and care for the child’s emotional 
health, during therapy and long after into adulthood. 
Perhaps if we collectively take care to consider 
‘children’, ‘families’ and ‘survivors’ rather than 
‘cases’, we will together establish a level ground 
on which we can both treat the cancer, and heal 
the spirit in equal measure to set the child up for a 
healthy, happy future. 
Abby White
Chief Executive: World Eye Cancer Hope UK 
www.wechope.org
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